SHP2-IN-9（Cat No.:I043934）is a potent and selective inhibitor of SHP2 (Src homology region 2-containing protein tyrosine phosphatase 2), a critical regulator of cell signaling pathways involved in growth, differentiation, and survival. By targeting SHP2’s phosphatase activity, SHP2-IN-9 disrupts downstream signaling of receptor tyrosine kinases, particularly the RAS/MAPK pathway, making it valuable in cancer research. It shows promise in treating malignancies driven by SHP2 mutations or hyperactive RAS signaling, such as leukemia and solid tumors. SHP2-IN-9 is widely used to investigate oncogenic signaling and explore targeted therapeutic strategies.